Literature DB >> 26983778

A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers.

David E Amacher1.   

Abstract

Context The silencing or activation of cancer-associated genes by epigenetic mechanisms can ultimately lead to the clonal expansion of cancer cells. Objective The aim of this review is to summarize all relevant epigenetic biomarkers that have been proposed to date for the diagnosis of some prevalent human cancers. Methods A Medline search for the terms epigenetic biomarkers, human cancers, DNA methylation, histone modifications and microRNAs was performed. Results One hundred fifty-seven relevant publications were found and reviewed. Conclusion To date, a significant number of potential epigenetic cancer biomarkers of human cancer have been investigated, and some have advanced to clinical implementation.

Entities:  

Keywords:  DNA methylation; Epigenetic biomarkers; human cancers; microRNAs

Mesh:

Substances:

Year:  2016        PMID: 26983778     DOI: 10.3109/1354750X.2016.1153724

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  2 in total

1.  The role of epigenomics in personalized medicine.

Authors:  Mohamad M Kronfol; Mikhail G Dozmorov; Rong Huang; Patricia W Slattum; Joseph L McClay
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-01-31

Review 2.  The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.

Authors:  Christian Bronner; Marc Mousli; Waseem Ashraf; Abdulkhaleg Ibrahim; Mahmoud Alhosin; Liliyana Zaayter; Khalid Ouararhni; Christophe Papin; Tanveer Ahmad; Ali Hamiche; Yves Mély
Journal:  Oncotarget       Date:  2017-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.